Skip to main content
. Author manuscript; available in PMC: 2025 Aug 28.
Published in final edited form as: Free Radic Biol Med. 2025 Jun 24;238:473–495. doi: 10.1016/j.freeradbiomed.2025.06.040

Table 3.

Mitochondrial transplantation effect to prevent drug-related toxicity.

Author/Year Model/Disease Mitochondria source Transfer parameters Clinical & biological evidences Mitochondrial mechanisms modulation

Jin 2024 [90] C57BL/6N mice
Doxorubicin cardiotoxicity
MSC cells
Not specified
Dose: 3 mg/kg
Administration: IV
Site: not specified
Restore ejection fraction and fractional shortening
↓ fibrosis
↓ apoptosis
↑ ATP level
↑ mito quantity (image)
↑ anti-ox (mRNA Sdhaf2/4)
↓ autophagy (mRNA LC3BII, p62)
↓ autophagosomes (inhibit AMPK/mTOR pathway)
Kim 2024 [91] Sprague Dawley rat
Dexamethasone related amyotrophy
UC-MSC cells
Human
Xenogeneic
Doses: 0.5–5 μg/limb
Administration: IM
Site: soleus
Positive effect with 5 μg
Recover muscle mass, fiber area, desmin, myogenin
↓ lactate
Act AMPK/AKT/Foxo pathway (↑Akt, ↓ FOXO3, ↓ MuRF-1, ↓ MAFbx)
↑ OXPHOS (CI, II, IV, V activity)
↑ mito biosynthesis (PGC-1, TFAM)
Kubat 2024 [92] Sprague Dawley rat
Doxorubicin muscular toxicity
Femoris
Rat
Allogenic
Dose: 6.5 μg mito proteins
Administration: IM
Sites: 3 tibialis
No protective effect
No effect on apoptosis
No effect on inflammation
↑ anti-ox (succinate DH, SOD)
Maia 2023 [93] SWISS mice
Oxaliplatin neurotoxicity
Liver
Mice
Allogenic
Dose: 0.5 mg/kg
Administration: IV
Site: retro-orbital
↓ cold mechanical and sensitive alteration
↓ neuro-inflammation (TNFα, TLR4)
Not investigated
Maleki 2023 [94] Wistar rat
Doxorubicin cardiotoxicity
Liver
Rat
Allogenic
Dose: 8*109 mito
Administration: IV
Site: tail
Restore ejection fraction and fractional shortening
↓ apoptosis
↓ inflammation (TNFα, IL1β, IL6)
↑ ATP level
↓ oxidative stress markers (MDA)
↑ anti-ox (SOD, CAT, GPX, GSH)
Sun 2023 [95] C57BL/6 mice
Doxorubicin cardiotoxicity
Heart
Mice
Allogenic
Dose: 105 mito
Administration: intraventricular
Site: cardiac
↑ ejection fraction and fractional shortening
↓ apoptosis
↓ Superoxide (mitosox probe)
↑ anti-ox (SOD2, OGG1)
↑ mito function (IDH2, citrate synthase)
↑ mitogenesis (PGC1-b)
↑ fusion (Opa1)
↑ OCR/ECAR ratio
Act glutamine & glutamate metabolic pathway
Zhang 2023 [96] C57BL/6 mice
Doxorubicin cardiotoxicity
Heart
Mice
Allogenic
Dose: 5*104 mito
Administration: intraventricular
Site: cardiac
↑ ejection fraction and fractional shortening ↑ mito quantity (hs & ms mtDNA)
↓ intracellular ROS, ↑ mito ROS
↑ MMP
↑ baseline and max OCR
Alexander 2021 [97] C57BL/6J mice
Cisplatin neurotoxicity
MSC cells
Human
Xenogeneic
Dose: 170 μg mito proteins Administration: intra-nasal ↑ executive functioning
Restore spatial/working memory
Restore synaptic damage
↓ atypical mito morphology
↓ synaptosomal mito damage
↑ anti-ox (Nrf2)
Kubat 2021 [98] Sprague Dawley rat
Doxorubicin nephrotoxicity
MSC cells
Rat
Allogenic
Dose: 4*106 mito Administration: injection Site: below kidney capsule ↑ cellular regeneration
↓ apoptosis
↓ proteinuria
↑ anti-ox (SOD, GPX)
Ulger 2021 [99] Sprague Dawley rat
Acetaminophen hepatotoxicity
MSC cells
Rat
Allogenic
Dose: 8.2*106 mito
Administration: injection
Site: subscapular spleen
↓ histological alteration
↓ apoptosis and ALAT
↓ anti-ox (GSH)
Shi 2018 [100] Sprague Dawley rat
Acetaminophen hepatotoxicity
HepG2 cells
Human
Xenogeneic
Dose: 10 mg/kg (fresh or fractioned)
Administration: IV
Site: tail
Results obtained only for fresh mito
↓ histological alteration
↓ ALAT and ASAT
↑ ATP level, only for intact mito
↑ anti-ox (GSH), only for intact mito
↓ ROS, only for intact mito

Akt: protein kinase B, ALAT: alanine aminotransferase, AMPK: AMP-activated protein kinase, anti-ox: anti-oxidant; ASAT: aspartate aminotransferase, ATP: adenosine tri-phosphate, CAT: catalase, ECAR: extracellular acidification rate, FOXO: forkhead box O, GPX: glutathione peroxidase, GSH: Reduced glutathione, IDH2: isocitrate dehydrogenase 2, IL: interleukin, IM: intra-muscular, IV: intra-veinous, LC3: microtubule-associated protein light chain 3, mito: mitochondria, MAFbx: muscle atrophy F-box, MDA: malondialdehyde, MMP: Mitochondrial membrane potential, MSC: mesenchymal stromal cell, mTOR: mammalian target of rapamycin, MuRF-1: muscle RING finger protein 1, NRF2: nuclear factor erythroid 2, OCR: oxygen consumption rate, OGG1: 8-oxoguanine DNA glycosylase 1, OPA1: optic atrophy 1, OXPHOS: oxidative phosphorylation, PGC1b: Pparg coactivator 1-b, ROS: relative oxygen species, Sdhaf: Succinate dehydrogenase assembly factor 1, SOD: superoxide dismutase, TFAM: mitochondrial transcription factor A, TLR4: Toll-like receptor 4, TNFα: tumor necrosis factor α, UC-MSC: Umbilical-cord MSC, ↑: increase/improve, ↓: decrease.